ZEFIOR Trademark

Trademark Overview

On Wednesday, February 7, 2018, a trademark application was filed for ZEFIOR with the United States Patent and Trademark Office. The USPTO has given the ZEFIOR trademark a serial number of 87787810. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 30, 2021. This trademark is owned by JOHNSON & JOHNSON. The ZEFIOR trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; pharmaceutical preparations in the nature of anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives
zefior

General Information

Serial Number87787810
Word MarkZEFIOR
Filing DateWednesday, February 7, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 30, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 29, 2018

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; pharmaceutical preparations in the nature of anxiolytics; pharmaceutical anti-allergic preparations and substances; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 15, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJOHNSON & JOHNSON
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJOHNSON & JOHNSON
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Monday, August 30, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 30, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 1, 2021EXTENSION 5 GRANTED
Tuesday, January 12, 2021EXTENSION 5 FILED
Monday, February 1, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 12, 2021TEAS EXTENSION RECEIVED
Wednesday, July 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 13, 2020EXTENSION 4 GRANTED
Monday, July 13, 2020EXTENSION 4 FILED
Monday, July 13, 2020TEAS EXTENSION RECEIVED
Tuesday, January 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 3, 2020EXTENSION 3 GRANTED
Friday, January 3, 2020EXTENSION 3 FILED
Friday, January 3, 2020TEAS EXTENSION RECEIVED
Tuesday, July 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 28, 2019EXTENSION 2 GRANTED
Friday, June 28, 2019EXTENSION 2 FILED
Friday, June 28, 2019TEAS EXTENSION RECEIVED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 1 GRANTED
Wednesday, December 19, 2018EXTENSION 1 FILED
Wednesday, December 19, 2018TEAS EXTENSION RECEIVED
Tuesday, July 24, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 29, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 26, 2018ASSIGNED TO LIE
Monday, April 16, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 13, 2018EXAMINER'S AMENDMENT ENTERED
Friday, April 13, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 13, 2018EXAMINERS AMENDMENT E-MAILED
Friday, April 13, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, April 12, 2018ASSIGNED TO EXAMINER
Thursday, February 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 10, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

zefior diseases preparations pharmaceutical system anti digital ophthalmic respiratory oncologic related